What the company does
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic …
What the weekly tape is saying
MRNA closed the latest completed week at 44.05 EUR. The 4-week return is 6.1% and the 12-week return is -1.7%. Trend Signal is active, Market Dynamics is -0.80. Setup signature: Balanced read with a 55/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 37.49 EUR
- Vs Trend Line
- 17.5%
- Fair Value
- 59.58 EUR
- Vs Fair Value
- -26.1%
- 52W High
- 50.45 EUR
- 52W Low
- 19.48 EUR
- Drawdown
- -12.7%
- Range Position
- 79.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 23 weeks
- 52W Active Weeks
- 23
- 52W Active Breadth
- 44.2%
- Sector Scope
- AT Healthcare
- Sector Rank
- 11 of 112
- Sector Percentile
- 91.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 39 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Biotechnology
- Tracked Peers
- 21
- 4W Rank
- 8 of 21
- Avg 1W
- -2.5%
- Avg 4W
- 0.3%
- Trend Breadth
- 23.8%
- Positive RS
- 9.5%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.80
- 4W MD Change
- -127.7%
- Relative Strength
- 17.24
- 4W RS Change
- -15.7%
- Expectation
- Undecided
- Probability
- 46.17%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 4.2K
- 13W Average
- 6.0K
- 52W Average
- 8.2K
- Vs 13W
- 0.7x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.6%
- 52W Volatility
- 8.1%
- Upside Weeks
- 28
- Downside Weeks
- 24
- Downside Breadth
- 46.2%
- Avg Gain / Loss
- 7.6% / -5.5%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 16.0B
Opportunity signals
- Trend Signal is active with a 23-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 44.05 EUR | 4.0% | 37.49 EUR | 59.58 EUR | -0.80 | 17.24 | 4.2K | On |
| 5 Jun 2026 | 42.35 EUR | 4.6% | 36.72 EUR | 60.04 EUR | -0.74 | 16.58 | 6.3K | On |
| 29 May 2026 | 40.47 EUR | -0.5% | 35.99 EUR | 60.50 EUR | -0.55 | 10.82 | 3.0K | On |
| 22 May 2026 | 40.69 EUR | -2.0% | 35.43 EUR | 61.03 EUR | -0.49 | 15.00 | 4.6K | On |
| 15 May 2026 | 41.52 EUR | -11.2% | 34.84 EUR | 61.52 EUR | -0.35 | 20.46 | 11.1K | On |
| 8 May 2026 | 46.74 EUR | 15.9% | 34.21 EUR | 62.00 EUR | -0.11 | 36.00 | 6.6K | On |
| 1 May 2026 | 40.33 EUR | -7.8% | 33.42 EUR | 62.46 EUR | 0.06 | 20.25 | 3.7K | On |
| 24 Apr 2026 | 43.72 EUR | -5.3% | 32.87 EUR | 62.99 EUR | 0.42 | 31.77 | 4.0K | On |
| 17 Apr 2026 | 46.15 EUR | 3.5% | 32.10 EUR | 63.48 EUR | 0.78 | 35.04 | 5.2K | On |
| 10 Apr 2026 | 44.60 EUR | 4.9% | 31.27 EUR | 64.01 EUR | 1.01 | 34.69 | 3.0K | On |
| 3 Apr 2026 | 42.51 EUR | -2.9% | 30.50 EUR | 64.64 EUR | 1.31 | 37.53 | 2.8K | On |
| 27 Mar 2026 | 43.77 EUR | -2.3% | 29.79 EUR | 65.29 EUR | 1.59 | 47.53 | 10.7K | On |
| 20 Mar 2026 | 44.81 EUR | -1.4% | 29.01 EUR | 65.90 EUR | 1.68 | 53.99 | 13.0K | On |
| 13 Mar 2026 | 45.45 EUR | 5.6% | 28.30 EUR | 66.51 EUR | 1.65 | 55.00 | 28.0K | On |